The chart review found that 3% of the patients who underwent detoxification with a long-acting benzodiazepine experienced hallucinations, compared with none of the phenobarbital patients (P = .013).

Of the 205 patients enrolled, 66 received lorazepam, 68 received diazepam, and 71 received placebo. Status epilepticus had been terminated on arrival at the emergency department in more patients ...